Skip to main content
Osteoarthritis and Cartilage Open logoLink to Osteoarthritis and Cartilage Open
. 2021 Jan 19;3(1):100137. doi: 10.1016/j.ocarto.2020.100137

Improved function and strength in patients with knee osteoarthritis as a result of adding a two-day educational program to usual care. Prospective randomized trial

MU Rezende a,, NLR Brito a, FES Farias a, CAC Silva a, CHA Cernigoy a, JM Rodrigues da Silva b, MM Moreira a, OFN Santana a, MI Hissadomi a, R Frucchi a, T Pasqualin a, GC Campos c, AF Pailo a, GP Ocampos a, OP Camargo a
PMCID: PMC9718166  PMID: 36475075

Abstract

Objective

The primary aim was to quantify the improvements on function and pain of patients with knee osteoarthritis (KOA), short education and low income by a two-day self-management program. Secondary aims were verifying if the program improves clinically relevant measures of weight and strength.

Design

A prospective randomized clinical trial was conducted in a tertiary hospital in Brazil with 191 patients with Kellgren & Lawrence grades II and III KOA who were allocated to two groups: control (usual care- CG) and intervention (usual care and two days of an OA self-management program with a multiprofessional team - IG). Western Ontario and McMaster Universities Index (WOMAC), weight, body mass index (BMI), Timed up and go (TUG) and five Times Sit to Stand Test (FTSST) were assessed at baseline, six, 12 and 24 months.

Results

Groups were similar at baseline (p ​> ​0.05). Both groups exhibited improved WOMAC total and subsets scores throughout the study (p ​< ​0.001). However, only IG improved WOMAC total and subsets in all follow-ups above 20% (minimally clinically important difference), with differences in WOMAC pain, function and total scores (p ​= ​0.001, p ​< ​0.001, and p ​< ​0.001, respectively) and best effect sizes at 1 year (0.355, 0.651 and 0.770, respectively). IG group lost weight (p ​< ​0.001) and BMI (p ​< ​0.01). Both groups exhibited improvements in TUG and FTSST (p ​< ​0.001) that remained in all evaluations. FTSST results favored the IG, p ​= ​0.032.

Conclusions

An educational program to patients with KOA, short schooling and low income improves clinically important measures of pain and function.

Keywords: Knee osteoarthritis, Education, Clinical trial, Minimal clinically important difference, Differential threshold

1. Introduction

Osteoarthritis (OA) is recognized as a mechanical [[1], [2], [3], [4], [5], [6]], inflammatory [[1], [2], [3], [4], [5], [6]] and metabolic [[7], [8], [9]] disease. OA is the leading skeletal cause of the number of years that individuals have lived with a disability [10,11], mainly because it is genetic [12] and related to longevity and obesity [13], both of which are exhibiting worldwide increases [14,15]. Unfortunately, sociodemographic factors, such as low levels of education and low income, are directly related to the risk of OA hospitalization [16].

Latin America (particularly Brazil) is considered a low-income country with both a high population and low levels of education, which places the country at high risks for OA and hospitalization. Currently, Brazil has a population of 210,147,125 and a life expectancy of 76.5 years (men: 73 years; women: 80 years). Men over 40 years of age represent 18% of the population, whereas women over 40 years of age represent 20.65% of the population [17]. In 2018, the income per capita was 360.00 USD [18]; in 2016, 51% of the adult population (66.3 million people) had completed first eight years of education [19]. Both overweight and obese are prevailing conditions among Brazilians. In 2015, 56.9% of the population was overweight, and 20.8% of the population was obese [20].

Physical activity is not a regular habit among Brazilians and is related to the level of education (9% of people without education practiced some type of physical activity, in comparison to 35.1% of people with higher education levels). In 2015, 18.4% of the population between 40 and 59 years practiced some type of physical activity (39.3% in soccer activities and 24.6% in walking activities), as did 13.4% of the Brazilians over 60 years of age [21].

Education, exercise, diet (if overweight) and the self-management of OA are considered by most guidelines to be some of the core treatment modalities for knee OA (KOA) [[22], [23], [24], [25], [26], [27]]. Despite a relatively small effect size of education, it can influence disease knowledge and self-efficacy when paired with other treatments [26,27].

In the scenario presented in Brazil (as well as in Asia, Africa and Latin America) involving an aging population with low socioeconomic levels as well as with a poor diet and lifestyle [20,21,28,29], interventions that are directed at educating patients on OA and its causes, risks and management seem to be necessary because of the lack of common knowledge concerning these factors. A pilot program was performed with 200 patients, and few differences were observed among the interventions [30,31]. Based on this pilot study, we developed this prospective randomized study of a multiprofessional educational program for patients with KOA who had low education levels and income.

The aim of this study was to investigate the effectiveness of a two-day OA educational program in addition to usual care, on physical function and pain in people with KOA in Brazil. Our program targets people with low levels of education and low-income attending care in a public hospital.

2. Patients and methods

2.1. Setting

This study was performed at the Department of Orthopedics and Traumatology–Osteometabolic Group–Hospital das Clínicas–University of São Paulo–Outpatients Clinic.

Ethics Committee for Analysis Certificate - CAAE 37436114.6.0000.0068.

Clinical Trials registration number: NTC 02335034.

2.2. Design

This study was a single-blind, single center, prospective randomized controlled clinical trial that was conducted in a tertiary orthopedic center.

This study followed the guidelines of the CONSORT statements for randomized controlled trials and nondrug treatments [32].

2.3. Participants

Volunteers were in a waiting list for knee OA clinical treatment. Participants were either patients from the knee group of the institution with OA but without indication for surgery or patients referred by employees of the hospital and by patients of the pilot program33.

Patients who met the following criteria were eligible for inclusion in the study: outpatients aged 40 years or older with KOA (according to the American College of Rheumatology clinical and radiological definitions with Kellgren & Lawrence [K&L] stages 1–3) with no rheumatologic diseases (other than OA), with indications for clinical treatments for OA, without any neurological problems or instability that would prevent them from exercising and with the ability to understand and provide informed consent, i.e., if they were not able to read, a family member read to them and they signed. The exclusion criteria included participating in another program with nutritional guidance.

2.4. Randomization

Two hundred and twenty-two sealed, opaque and nontranslucent envelopes containing a card indicating CG or IG were mixed in an urn. After signing the informed consent, the patient chose a card from the urn and opened it in front of an assistant of the project. A second assistant unrelated to the research was responsible for informing and directing patients to the subsequent routine.

2.5. Intervention

Among the care providers were orthopedic surgeons, one nutritionist, psychologists, social workers, physical and occupational therapists and physical educators.

The participants in the intervention group (IG) participated in two days of a structured educational and exercise-based self-management program that were held two months apart. The participants received written and video (DVD) educational material on the first intervention day, with the material describing what was taught in the interventions and including directions for all of the community centers and primary and secondary care centers of the city of São Paulo, where the participants could continue the program near their house (in case they did not want to exercise alone at home). These directions were compiled by the social workers.

This study followed a similar protocol as that described in our pilot study that was based on in programs described in the literature [30,31,33]; however, this study had an increased emphasis on physical fitness [34]. The interventions were conducted over 2 separate days of classes.

The first day of lecture was conducted from 8:00 a.m. to 5:00 p.m. Each of the lectures lasted approximately 40 ​min to an hour and were provided by a total of seven different teams.

The orthopedic surgeons explained the anatomy, joints, the OA disease, the risk factors and the treatment modalities to the participants.

The psychologists discussed personality characteristics that exist from childhood to adulthood as well as the difference between having a disease and being sick, the importance of their choices (and not their conditions or feelings) and coping skills.

The nutritionist emphasized the importance of a well-balanced diet (reduced quantity of food as well as the importance of colorful whole grains and low-calorie meals). During the intervention, patients were given a break every 3 ​h and were provided with meals that followed the instructions that were given by the nutritionist; thus, the patients personally experienced a day’s worth of the options of the proposed diet.

The physical therapists re-enforced the importance of the previously mentioned nutritional options as well as the importance of hydration. Additionally, they introduced the benefits of regularly performing physical exercises (at least three times a week as part of a group [if possible] and with comfortable clothing), types of exercises (stretching, isometric and isotonic strengthening), adequate posture when performing exercises and the importance of controlled load (with respect to personal limitations). The therapists clarified to the patients that the benefits of the exercises are in the prevention and control of preexisting diseases. They also explained the difference between physical activity and physical exercise.

The occupational therapists introduced the importance of protecting the joints during daily activities by optimizing ergonomics and by alternating among different levels of energy expenditure.

The physical education professionals (similarly to the physical therapists) also lectured about the health-related benefits of physical exercise and its role in KOA management as well as on the differences between physical activity and exercise and the importance and methods of how to improve physical fitness.

After these lectures, the patients participated in the following 3 workshops that lasted 50 ​min each:

  • (1)

    Physical therapy with stretching, isometric exercises and isotonic exercises (half of the exercises were performed with a chair, either in a seated position or by standing and leaning on the chair, and half of the sessions were performed by lying down on a stretcher). Instructions on how to use weights to progressively increase weight loads at home were discussed and written in a booklet that was given to all of the patients. Physical therapists instructed patients in performing the exercises at least three times a week.

  • (2)

    The physical fitness workshop [34] focused on how to perform exercise (resistance and aerobic types) at home by using low-cost alternative tools as well as how to exercise at the appropriate exercise intensity. Patients were instructed to perform 30–60 ​min/day (in sessions of at least 10 ​min) of moderate-intensity aerobic exercise (11–13 in the 6–20 rating of perceived exertion scale, or RPE) [35] for 5 days a week. Alternatively, when considering the moderate-intensity aerobic exercise recommendation and if physical capacity and disease severity permitted, the participants were instructed to perform 20–30 ​min/day (in sessions of at least 10 ​min) of vigorous-intensity aerobic exercise (14–16 ​at the 6–20 RPE) [35] for 3 days a week. Patients were instructed to perform the type of aerobic exercise that they preferred (for example, walking, stationary cycling, dancing and swimming, among other types). However, if weight-bearing aerobic exercise was not tolerated (for example, due to knee pain that would become increased during or after the exercise), they were instructed to perform stationary cycling or aquatic exercise. In addition to aerobic exercise recommendations, the volunteers were instructed to perform 2–3 sets of 8–12 repetitions (1–2 ​min of rest intervals between sets) of 10 resistance exercises (bench press, squat, seated row, knee extension, shoulder press, knee curl, triceps pushdown, calf raise, biceps curl and abdominal exercises) for 3 times a week (on nonconsecutive days). The patients were taught that they could perform the resistance exercises by using weight-lifting machines, weight bearing, dumbbells or some adapted materials that were described in the classes (using ankle weights, bars, elastic bands and bottles filled with water or sand) at an intensity between 14 and 17 ​at the 6–20 RPE scale [35], while simultaneously avoiding the Valsalva maneuver.

  • (3)

    The occupational therapy team instructed the patients in a simulated safe house, where they were shown how to protect their joints in daily living activities, such as activities involving organizing, cleaning, squatting, raising items, sitting, sleeping, labor work, ironing clothes, activities in the kitchen and activities in the bathroom.

After a break in the afternoon, patients would attend a final short lecture with the social workers that emphasized the need to perform habits including regular leisure, sports, social gathering and volunteering.

Each team emphasized the importance of the participants in changing their habits.

At the end of the first intervention day, the patients received the educational material with instructions to read or watch the material at least three times. All of the information that was provided to the patients was able to be accessed in the program’s book [36].

Two months later, a second day of interventions was conducted from 8:00–16:00 hs.

The social workers asked if the patients had included new habits and what the new habits were, while also providing options of habits to discuss.

The nutritionist reviewed the slides of her lecture in the first intervention and asked the patients what they remembered and what questions they had about their diets.

The patients then participated in the following 4 workshops:

The physical therapy and physical fitness workshops were very similar to the first intervention, with these workshops solely attempting to increase the weight loads and to correct techniques.

The occupational therapy workshop focused on distributing the light and heavy activities of daily living during the day and week, with a specific focus on joint protection and on conserving energy.

The psychology workshop focused on psychological educational and therapeutic group sessions with the patients, with a focus on what the patients had done since the time of the first intervention, in respect to their arthritis [37,38].

The orthopedic team finalized the steps of this intervention by asking questions about the disease and self-management. The final discussion focused on exercising and dieting, according to the program.

2.6. Usual care/Aftercare/follow-up routine

Patients of both groups were seen by the orthopedic surgeons at inclusion, six, 12 and 24 months. The six-month evaluation occurred six months after the inclusion and 3–4 months after the second day of the intervention, whereas the one-year and two-year evaluations were conducted 11 months and 23 months, respectively, after the second intervention. At inclusion patients were already receiving diacerhein and/or analgesics such as paracetamol, codeine and/or dipyrone that were prescribed by the physicians when patients were first seen (either in the knee group or in the osteometabolic group) and sent to the waiting list for OA clinical treatment. At each visit since the inclusion, the medical team explained the disease and its forms of treatment based on international guidelines [[22], [23], [24], [25], [26], [27]] and prescribed whatever services they considered appropriate including the need to diet and exercise, orthotics, and medications to each patient [[22], [23], [24], [25], [26], [27],39].

2.7. Outcome measures

The primary aim of this study was to evaluate the improvement in physical function of the patients at two years. Secondarily was to evaluate improvements in function in six and 12 months, pain at six, 12 and 24 months. At each follow-up evaluation verify if improvement reaches minimum clinically important differences (MCID), minimum important changes (MIC) and/or minimum detectable change (MDC). Secondary objectives also included to verify if the program leads to clinically relevant improvements in weight, body mass index (BMI), waist/hip ratio (WHR), and objectives measures of strength such as timed up and go (TUG) and five times sit to stand test (FTSST) at six, 12 and 24 months.

At the time of enrollment and at 6, 12 and 24 months (on the same day of the medical consultation in the hospital), the patients were asked to complete the WOMAC questionnaire [40]. The nutrition team measured weight, height, abdominal circumference, hip circumference and seven skin folds to calculate the body mass index (BMI), the waist hip ratio (WHR) and the percentage of body fat (PBF) [41,42]. Patients performed TUG [43] and FTSST [44] with the physical therapy team. VAS and SF-36, DASH (The Disabilities of the Arm, Shoulder and Hand Score) and HAQ (The Health Assessment Questionnaire) were obtained in all time points, but the data were not yet evaluated. PBF results were not shown due to similar measures (BMI, WHR).

To evaluate if improvements in WOMAC total and subsets were clinically important we created a table of the average results of WOMAC total and subset at every follow-up performed in the Brazilian version (0–96) and as a percentage in a reverse format consisting of a range from 0 (worst) to 100 (best) in order to compare our results to those described as significant improvements in rehabilitation trial [45,46], and in total knee arthroplasty (TKA) [47].

2.8. Sample size

The “n” was calculated to obtain a statistical power of 80% and a significance level of 5%. For these calculations, we considered the mean and standard deviation of the WOMAC questionnaire (our primary outcome) from one of the pilot studies (WOMAC of 48.8 and standard deviation of 15.8) [33]. We sought a sample size that would allow the detection of a 20% variation in the questionnaire. When considering a possible dropout rate of approximately 20%, the result of 76 patients per group was obtained.

2.9. Blinding

When signing the informed consent forms, the patients knew that they would either be selected for a group that would receive the standard care for OA or for a group in which they would also be offered lectures about the disease. The evaluators were blind to the groups that the patients belonged to. Two main assistants scheduled appointments and classes, retrieved material and plotted the questionnaires’ results in Excel sheets.

2.10. Statistical analysis

Patients missing the first or both interventions, missing two follow-up visits, undergoing surgery related or not to OA during the study that would prevent daily regular exercises or that would improve pain and functional performance were not analyzed.

The quantitative personal and clinical characteristics are described (according to the groups) with descriptive statistics (means, standard deviations, medians, minimums and maximums) and were compared between groups by using Mann-Whitney or Student’s t-tests. Qualitative characteristics (race) are described according to groups, and the association was verified with the use of the chi-square test or exact tests. As the comparison involves two factors (group and time), first the interaction between the two factors was evaluated, to know if the behavior of one factor does not differ when the category changes in the other factor (interaction), if this occurred the comparison was carried out in detail, i.e., each group was compared between the moments (p group) and the groups were compared at each moment (p moment). When the interaction did not occur, i.e., groups behaved similarly between the moments, groups were compared without taking into account the moment (p group) and moments were compared without considering the groups (p moment).

WOMAC domains are described according to groups and evaluation times by using summary measures and were compared according to groups and times by using generalized estimation equations with a Poisson marginal distribution and the identity link function. The other evaluated parameters were assumed to have a normal distribution with an identity link function, and a first-order autoregressive correlation matrix was used between the moments of the evaluation for all of the analyses. The analyses were followed by the use of Bonferroni’s multiple comparisons to verify where the differences between the groups and the evaluation times occurred, when the results were observed to be significant. The analyses were performed by using IBM-SPSS for Windows version 20.0 and were tabulated by using Microsoft-Excel 2010; the tests were performed with a significance level of 5%.

3. Results

The flowchart of the study is presented in Fig. 1. Three hundred thirty-one patients were assessed for study eligibility in January 2015. Two hundred twenty-one patients met the inclusion criteria and were allocated into two groups. In the IG, 15 participants missed the first and/or both interventions, and one patient died. In the CG, six patients declined to continue participation at 6 months, and nine patients declined to continue participation at the one-year follow-up. At the 24-month follow-up, there were 96 patients in the control group and 95 patients in the intervention group.

Fig. 1.

Fig. 1

CONSORT 2010 flow diagram.

Table 1 shows the personal and clinical characteristics according to group. The groups were similar in all aspects.

Table 1.

Baseline personal and clinical characteristics according to group.

Variables Group
Control (N ​= ​96) Intervention (N ​= ​95)
Age (years)
mean ​± ​SD 63.2 ​± ​8.7 63.8 ​± ​9.5
median (min.; max.) 63.5 (43; 83) 63 (42; 86)
Years of schooling
mean ​± ​SD 5.8 ​± ​4.6 5.9 ​± ​4.7
median (min.; max.) 4 (0; 15) 4 (0; 16)
Physical Activity (IPAQ)
mean ​± ​SD 2.8 ​± ​1.3 3.3 ​± ​1
median (min.; max.) 2 (1; 5) 3 (1; 5)
Gender. n (%)
Male 20 (20.8) 16 (16.8)
Female 76 (79.2) 79 (83.2)
Race. n (%)
White 55 (57.3) 60 (63.2)
Black 16 (16.7) 15 (15.8)
Mulatto/Mestizo 20 (20.8) 16 (16.8)
Asian 5 (5.2) 4 (4.2)
K&L right. n (%)
1 6 (6.3) 5 (5.3)
2 54 (56.3) 40 (42.6)
3 36 (37.5) 49 (52.1)
K&L left. n (%)
1 4 (4.2) 7 (7.4)
2 59 (61.5) 44 (46.8)
3 33 (34.4) 43 (45.7)
WOMAC Pain
mean ​± ​SD 10.7 ​± ​4.1 10.3 ​± ​3.9
median (min.; max.) 11 (1; 20) 10 (1; 20)
WOMAC Stiffness
mean ​± ​SD 4.4 ​± ​2 4.1 ​± ​2
median (min.; max.) 5 (0; 8) 4 (0; 8)
WOMAC Function
mean ​± ​SD 38.2 ​± ​14.3 37.3 ​± ​13.8
median (min.; max.) 41 (0; 68) 40 (1; 68)
WOMAC Total
mean ​± ​SD 53.4 ​± ​19.1 51 ​± ​18.2
median (min.; max.) 55.5 (4; 96) 53 (2; 96)
Weight (Kg)
mean ​± ​SD 80.8 ​± ​16.1 77.9 ​± ​16.9
median (min.; max.) 79.4 (50; 119.9) 75.6 (51.7; 141)
Body Mass Index
mean ​± ​SD 32 ​± ​6.1 31 ​± ​5.9
median (min.; max.) 32.5 (19.5; 50) 30 (21.1; 51.9)
Waist/Hip Ratio
mean ​± ​SD 1 ​± ​0.1 0.99 ​± ​0.11
median (min.; max.) 1 (0.74; 1.2) 0.99 (0.73; 1.27)
Percentage of Body Fat
mean ​± ​SD 39.4 ​± ​9 39 ​± ​7.7
median (min.; max.) 42.7 (11.2; 51) 39.9 (15.1; 66.1)
Time Up and Go Test
mean ​± ​SD 13.6 ​± ​5.9 15.6 ​± ​8.2
median (min.; max.) 12.2 (5.8; 40.2) 13.6 (6; 47.6)
Five Time Sit to Stand Test
mean ​± ​SD 28.6 ​± ​15.5 26.3 ​± ​11.6
median (min.; max.) 24.5 (10.7; 117.8) 22.7 (11.1; 59.7)

T-Student Test; ∗∗ Mann-Whitney Test; ∗ Qui-square Test; # likelihood ratio Test.

IPAQ – International Physical Activity Questionnaire.

3.1. WOMAC

Table 2 shows the difference in average behavior of the groups in WOMAC pain, function and total scores (p ​< ​0.05 in all evaluations between groups in all moments). The IG improvements in WOMAC pain, function and total scores were better than those of the CG in all follow-ups. At six and 12 months, WOMAC pain was better in the IG (p ​= ​0.029, ES 0.238, average difference 1.41, 95% CI 0.07, 2.76 and p ​< ​0.001 ​ES 0.355, average difference 2.09 95% CI 0.75, 3.42, respectively, Table 3). WOMAC function and total scores of the IG, despite better than those of the CG in all follow-up evaluations (p ​< ​0.001), lost some of the gains obtained in the first 12 ​months ​at 24 months, with moderate effect sizes at 12 months follow-ups (p ​< ​0.001, ES 0.651, mean difference 7.27, 95% CI 4.73, 9.81, and 0.770, mean difference 10.15 95% CI 7.16, 13.15, respectively, Table 3). Both groups improved WOMAC stiffness with better results at all follow-ups in the IG (p ​= ​0.001, ES ​= ​0.241, mean difference 0.65, 95% CI 0.27, 1.03). When considering a 12–15% reduction from a participant’s baseline WOMAC score as being a clinically meaningful improvement in OA in rehabilitation trials45,46, the IG group was the only group to achieve a clinically meaningful improvement in all of the WOMAC subsets and total in all of the follow-ups since the 6th month (Table 2). When compared to the meaningful improvements in total knee arthroplasty (TKA), neither the CG nor the IG reached MIC [47]. The IG group reached MCID values for TKA [47] at 6 and 12 months for all of the WOMAC subsets and for the total data, with these patients losing MCID at 24 months only for the WOMAC pain scores (Table 4). The IG group also reached TKA MDC [47] values for the WOMAC function at 6 and 12 months and for the WOMAC total scores at 12 months (Table 4).

Table 2.

Description of the WOMAC domains and the total score according to group and moment of evaluation and result of comparative tests.

Variable/Group Moment
p Group p Moment p Interaction
Baseline 6 months 12 months 24 months
WOMAC Pain <0.001 <0.001 0.001
Control
mean ​± ​SD 10.7 ​± ​4.1 9.5 ​± ​4.1 9.8 ​± ​4.5 9.4 ​± ​4.5
median (min.; max.) 11 (1; 20) 10 (1; 17) 10 (0; 20) 10 (1; 20)
Intervention
mean ​± ​SD 10.3 ​± ​3.9 8 ​± ​3.9 7.7 ​± ​3.9 8.1 ​± ​3.9
median (min.; max.) 10 (1; 20) 8 (0; 20) 8 (0; 16) 8 (0; 17)
WOMAC Stiffness 0.001 0.001 0.203
Control
mean ​± ​SD 4.4 ​± ​2 4.1 ​± ​1.9 4.2 ​± ​2 3.9 ​± ​2.1
median (min.; max.) 5 (0; 8) 4 (0; 8) 5 (0; 8) 4 (0; 8)
Intervention
mean ​± ​SD 4.1 ​± ​2 3.2 ​± ​1.8 3.3 ​± ​1.9 3.4 ​± ​1.9
median (min.; max.) 4 (0; 8) 3 (0; 7) 4 (0; 8) 3 (0; 7)
WOMAC Function <0.001 <0.001 <0.001
Control
mean ​± ​SD 38.2 ​± ​14.3 34.1 ​± ​14.1 35.1 ​± ​14.5 33.6 ​± ​14.2
median (min.; max.) 41 (0; 68) 36.5 (1; 65) 38 (2; 66) 36 (4; 64)
Intervention
mean ​± ​SD 37.3 ​± ​13.8 29.5 ​± ​15.2 27.8 ​± ​13.4 30 ​± ​13.8
median (min.; max.) 40 (1; 68) 33 (0; 63) 30 (0; 60) 34 (0; 54)
WOMAC Total <0.001 <0.001 <0.001
Control
mean ​± ​SD 53.4 ​± ​19.1 47.8 ​± ​19 49 ​± ​20.3 47 ​± ​19.7
median (min.; max.) 55.5 (4; 96) 51 (2; 89) 52 (3; 94) 50 (5; 89)
Intervention
mean ​± ​SD 51 ​± ​18.2 40.6 ​± ​19.8 38.8 ​± ​17.9 41.3 ​± ​18.2
median (min.; max.) 53 (2; 96) 45 (0; 90) 40 (2; 82) 44 (0; 77)

Generalized equations with Poisson distribution and identity function.

P group ​= ​Differences between groups in each moment.

P moment ​= ​Differences between moments in each group.

P interaction ​= ​differences in curves of the two groups during the study period.

Table 3.

Results of comparisons of WOMAC domains and the total score between groups or moments of evaluation.

Variable Group/Moment Comparison Mean difference Standard error p Effect size
MD CI(95%)
Low Upper
WOMAC Pain Control Baseline-6 months 1.2 0.28 <0.001 0.33 2.07
Baseline-12 months 0.89 0.36 0.356 −0.22 2.00
Baseline-24 months 1.28 0.41 0.047 0.01 2.56
6 months–12 months −0.32 0.27 >0.999 −1.17 0.54
6 months–24 months 0.08 0.36 >0.999 −1.05 1.21
12 months–24 months 0.40 0.29 >0.999 −0.51 1.31
Intervention Baseline-6 months 2.24 0.27 <0.001 1.41 3.08
Baseline-12 months 2.60 0.34 <0.001 1.55 3.65
Baseline-24 months 1.98 0.39 <0.001 0.77 3.19
6 months–12 months 0.36 0.25 >0.999 −0.41 1.13
6 months–24 months −0.26 0.33 >0.999 −1.29 0.77
12 months–24 months −0.62 0.26 0.469 −1,43 0.19
Baseline Control-Intervention 0.37 0.47 >0.999 −1.09 1.83
6 months Control-Intervention 1.41 0.43 0.029 0.238 0.07 2.76
12 months Control-Intervention 2.09 0.43 <0.001 0.355 0.75 3.42
24 months Control-Intervention 1.07 0.45 0.491 0.173 −0.34 2.48
WOMAC Stiffness Control-Intervention 0.65 0.20 0.001 0.241 0.27 1,03
Baseline-6 months 0.57 0.16 0.001 0.16 0.98
Baseline-12 months 0.53 0.19 0.024 0.04 1.02
Baseline-24 months 0.61 0.20 0.016 0.07 1.14
6 months–12 months −0.04 0.15 >0.999 −0.44 0.36
6 months–24 months 0.03 0.19 >0.999 −0.46 0.52
12 months–24 months 0.08 0.16 >0.999 −0.34 0.49
WOMAC Function Control Baseline-6 months 4.34 0.50 <0.001 2.77 5.91
Baseline-12 months 3.08 0.65 <0.001 1.06 5.11
Baseline-24 months 4.26 0.75 <0.001 1.91 6.60
6 months–12 months −1.26 0.49 0.295 −2,80 0.28
6 months–24 months −0.09 0.66 >0.999 −2.14 1.97
12 months–24 months 1.17 0.53 0.743 −0.48 2.82
Intervention Baseline-6 months 7.62 0.49 <0.001 6.09 9.14
Baseline-12 months 9.51 0.62 <0.001 7.58 11.43
Baseline-24 months 7.27 0.72 <0.001 5.03 9.51
6 months–12 months 1.89 0.45 0.001 0.48 3.30
6 months–24 months −0.34 0.61 >0.999 −2.24 1.56
12 months–24 months −2.23 0.47 <0.001 −3.7 −0.77
Baseline Control-Intervention 0.85 0.89 >0.999 −1.93 3.63
6 months Control-Intervention 4.12 0.82 <0.001 0.365 1.55 6.69
12 months Control-Intervention 7.27 0.81 <0.001 0.651 4.73 9.81
24 months Control-Intervention 3.87 0.86 <0.001 0.329 1.19 6.54
WOMAC total Control Baseline-6 months 6.02 0.56 <0.001 4.26 7.78
Baseline-12 months 4.46 0.73 <0.001 2.16 6.75
Baseline-24 months 5.97 0.86 <0.001 3.29 8.65
6 months–12 months −1.56 0.55 0.131 −3.29 0.16
6 months–24 months −0.05 0.75 >0.999 −2.38 2.28
12 months–24 months 1.52 0.59 0.297 −0.34 3.37
Intervention Baseline-6 months 10.01 0.54 <0.001 8.32 11.71
Baseline-12 months 12.23 0.69 <0.001 10.07 14.39
Baseline-24 months 9.35 0.81 <0.001 6.81 11.89
6 months–12 months 2.22 0.50 <0.001 0.65 3.79
6 months–24 months −0.66 0.68 >0.999 −2.80 1.48
12 months–24 months −2.88 0.53 <0.001 −4.52 −1.24
Baseline Control-Intervention 2.37 1.05 0.647 −0.89 5.64
6 months Control-Intervention 6.37 0.97 <0.001 0.479 3.35 9.39
12 months Control-Intervention 10.15 0.96 <0.001 0.770 7.16 13.15
24 months Control-Intervention 5.76 1.01 <0.001 0.416 2.62 8.90

MD CI 95% ​= ​95% confidence interval of the mean difference.

Table 4.

Mean values of WOMAC total and subsets as used in the Brazilian version (0–96) and as a percentage in a reverse format consisting of a range from 0 (worst) to 100 (best).

Variable/Group Baseline
6 months
12 months
24 months
Baseline
6 months
12 months
24 months
0–96 0–96 0–96 0–96 0–100 0–100 0–100 0–100
WOMAC Pain
Control 10.7 9.5 9.8 9.4 46.8 52.3 51.1 53.2
Intervention 10.3 8 7.7 8.1 48.6 60.1∗ 61.6∗ 59.3
WOMAC Stiffness
Control 4.4 4.1 4.2 3.9 44.8 48.2 47.5 51.2
Intervention 5 4 5 4 48.6 59.6∗ 59.1∗ 58.1∗
WOMAC Function
Control 38.2 34.1 35.1 33.6 43.8 49.8 48.3 50.6
Intervention 37.3 29.5 27.8 30 45.1 56.6∗# 59.1∗# 56∗
WOMAC Total
Control 53.4 47.8 49 47 44.4 50.3 49 51
Intervention 51 40.6 38.8 41.3 46.9 57.7∗ 59.6∗# 57∗

∗ MCID: Minimum Clinically Important Difference/∗∗MIC: Minimum Important Change/#Minimum Detectable Change for total knee Arthroplasty (TKA).

3.2. Weight, BMI and HWR

Whereas the CG maintained the same weight during the study, the IG exhibited a nonsignificantly reduced weight (p ​= ​0.132, Table 5), with the differences not reaching a minimally important difference. At 6, 12 and 24 months, the CG and the IG had 2, 7 and 7 patients and 4, 7 and 13 patients, respectively, who lost 5 ​kg of their weight or more. The WHR exhibited minor changes during the study (Table 5).

Table 5.

Description of anthropometric measurements and functional tests according to group and moment of assessment and results of comparative tests.

Variable/Group Moment
P Group P Moment P Interaction
Baseline 6 months 12 months 24 months
Weight (Kg) Control 0.152 0.001 0.107
Mean ​± ​SD 80.8 ​± ​16.1 80.8 ​± ​16.1 80 ​± ​15.7 79.8 ​± ​15.6
Median (min.; max.) 79.4 (50; 119.9) 78.6 (51.1; 126.9) 77.9 (50.5; 122.3) 77.4 (50.7; 125.2)
Intervention
Mean ​± ​SD 77.9 ​± ​16.9 77.1 ​± ​16.2 76.5 ​± ​15.9 75.9 ​± ​15.3
Median (min.; max.) 75.6 (51.7; 141) 75.4 (52.5; 126.8) 74.2 (52.8; 121.7) 75.2 (51.2; 123)
Body Mass Index Control 0.155 <0.001 <0.001
Mean ​± ​SD 32 ​± ​6.1 32 ​± ​6.1 31.6 ​± ​5.9 31.7 ​± ​6.1
Median (min.; max.) 32.5 (19.5; 50) 31.9 (19.3; 50.9) 31.4 (19.6; 48.5) 31.3 (19.4; 50.4)
Intervention
Mean ​± ​SD 31 ​± ​5.9 30.7 ​± ​5.8 30.4 ​± ​5.7 30.2 ​± ​5.5
Median (min.; max.) 30 (21.1; 51.9) 30.1 (21.2; 51.7) 29.7 (20.7; 52.1) 29.3 (21.1; 52.5)
Waist/Hip Ratio Control 0.765 0.525 0.038
Mean ​± ​SD 1 ​± ​0.1 0.99 ​± ​0.09 0.99 ​± ​0.09 0,99 ​± ​0.1
Median (min.; max.) 1 (0.74; 1.2) 0.99 (0.71; 1.17) 0.99 (0.74; 1.17) 1 (0.64; 1.22)
Intervention
Mean ​± ​SD 0.99 ​± ​0.11 0.99 ​± ​0.11 1 ​± ​0.11 0.98 ​± ​0.1
Median (min.; max.) 0.99 (0.73; 1.27) 0.99 (0.73; 1.2) 1 (0.77; 1.31) 0.97 (0.75; 1.26)
Time Up and Go Test Control 0.282 <0.001 0.151
mean ​± ​SD 13.6 ​± ​5.9 12.4 ​± ​6 11.8 ​± ​5 11.8 ​± ​4.9
median (min.; max.) 12.2 (5.8; 40.2) 11 (4.3; 37.9) 10.5 (6; 37.9) 10.5 (1; 28.7)
Intervention
mean ​± ​SD 15.6 ​± ​8.2 12.1 ​± ​6.3 11.8 ​± ​7.1 11.6 ​± ​4.5
median (min.; max.) 13.6 (6; 47.6) 10 (6.2; 45.3) 10.2 (5.1; 68) 10.5 (6.3; 29)
Five Time Sit to Stand Test Control 0.032 <0.001 0.352
mean ​± ​SD 28.6 ​± ​15.5 24.5 ​± ​15.4 22.6 ​± ​15 20.5 ​± ​8.6
median (min.; max.) 24.5 (10.7; 117.8) 20.1 (10.8; 116.1) 18.4 (10.1; 129.1) 17.9 (1.5; 53.2)
Intervention
mean ​± ​SD 26.3 ​± ​11.6 19.3 ​± ​7.4 19.7 ​± ​9 18.8 ​± ​11.5
median (min.; max.) 22.7 (11.1; 59.7) 17.5 (9.7; 46.3) 17.8 (9.8; 65.1) 16.1 (10; 105.3)

Generalized equations with Poisson distribution and identity function.

P group ​= ​Differences between groups in each moment.

P moment ​= ​Differences between moments in each group.

P interaction ​= ​differences in curves of the two groups during the study period.

3.3. TUG/FTSST

Table 5 shows that both groups exhibited improved TUG and FTSST results in all of the follow-up evaluations. The FTSST results were better in the IG in all of the evaluations since the sixth-month follow-up (p ​= ​0.032, ES ​= ​0.156, mean difference 2.89, 95% CI 0.25, 5.53).

3.4. Adverse events

There were no unexpected events to the general health of the patients except for improvement or not of the symptoms related to osteoarthritis.

4. Discussion

Primary care in Brazil has not standardized nonoperative treatments for OA, although this is not an exclusive issue of developing countries. In Sweden, more than 50% of patients with hip or knee OA are referred to surgery without receiving core treatment [48]. There are several guidelines for the treatment of OA, especially OA of the knee [25,[49], [50], [51]], that offer a variety of evidence and effect sizes of the several modalities of treatment. Low-grade inflammation plays an important role [[52], [53], [54]] in the perpetuation of the symptoms affecting many aspects of quality of life, not only joint pain. The determination of the subtlety of whether pain is myofascial, perimeniscal, synovial or from the bone (as well as whether pain is increased by low level inflammation) may not be easy for a primary care physician. Because OA is a component of metabolic syndrome [55], it has been suggested by most of the recent guidelines that patients must change their lifestyle, including changing their diet and exercise habits [49,50,56]. In 2012, a 6-week arthritis self-management program questioned its practicality, due to a lack of enthusiasm from potential referrers and patients [57]. The effect size of education has been thought to vary between −0.10, 95% CI (−0.19 to 0.01) [58] and 0.29 (0.17–0.41) [27] for pain. In Sweden, a national structured education- and exercise-based self-management program for patients with knee or hip OA revealed that patients with knee and hip OA experienced significant reductions in symptoms and a decreased willingness to undergo surgery, while simultaneously using less OA medication and taking less sick leave [48,59]. The results indicated that the offering of that program as the first-line treatment for OA patients may reduce the burden of this disease. These studies were not performed in low- or middle-income countries [27,39,57,[60], [61], [62], [63]]. In Brazil, as well as in other low- or middle-income countries, the population is aging, is gaining weight, possesses low education levels, possesses low income levels and does not exhibit exercise habits [17,20,21,28].

We decided to start a program in tertiary care that was led by orthopedic surgeons who are familiar with articular pain and who had acquired some experience with the clinical aspects of the disease. The remainder of the care team (social workers, a nutritionist, occupational therapists, physical therapists, psychologists and physical educators) had previous experiences with a multiprofessional educational program for osteoporosis that was led by professionals of the same institution [64].

The educational program was previously structured based on pilot studies [30,33,65,66]. We studied the effect of the two days of intervention at 6, 12 and 24 months after the initiation of the study in comparison to the effect of standard OA care by orthopedic surgeons. In this particular study, grade 4 ​K&L patients were excluded because of the diversity of the clinical presentations, especially in regard to instability (a factor that affects function), that can be observed among these patients.

Among the limitations of our study were the difficulties that our patients exhibited in answering questionnaires, which constituted the main reason for choosing WOMAC [67] and objective measures such as TUG and FTSST. This study consisted of a single center study with a specific team of surgeons who were willing to emphasize the importance of changing habits as well as the methods for changing these habits. Our care providers were orthopedic knee and sports medicine surgeons who were free to prescribe medications and therapies that they found appropriate [39], as in accordance with current guidelines [22,24,68]. However, the actual consuming of medications by patients (both for pain and for comorbidities) was not controlled. There was also no control for the actual type, intensity and frequency of physical activity and a consequent lack of correlation between exercise and improvement [69]. Food intake was also not controlled. Additionally, the control of comorbidities was not assessed; however, from our data, only 8 patients in the IG and 12 patients in the CG were not overweight or obese. Of these patients, one patient in each group had only one painful knee. All of the other nonoverweight participants had both knees involved. In this respect, we believe that the groups were similar and that the majority of the patients had, at least, one comorbidity. Another limitation of our study was lack of control of self-efficacy or disease knowledge.

The patients in both groups exhibited improved stiffness in all time points, with the best results observed in the IG. The IG exhibited improved pain at all of the time points, in respect to the baseline time point (p ​< ​0.01). In general, the IG improved at six months, maintaining results at the 12- and 24-month evaluations. There was a nonsignificant loss at 24 months (Table 2, Table 3) [39,45]. After the program, the WOMAC pain results were better in the IG than the CG, with small effect sizes of 0.238 and 0.355 ​at 6 and 12 months between groups (Table 3) [22,27,58,68]. The WOMAC function and the total data followed the improvements, as shown in the WOMAC pain scores, with moderate effect sizes at 12 months (0.651 and 0.707, respectively). During rehabilitation, a clinically meaningful improvement in OA was defined as a reduction of at least 12–15% from a participant’s baseline WOMAC score [39,45]. According to these parameters, since the 6th month, the IG achieved meaningful improvements in the total WOMAC and subset results, with the group maintaining improvements until the time of the final evaluation, as described by Hurley et al. [39], whereas the CG did not demonstrate this effect. When compared to improvements that are provided by TKA [47], at 12 months, 42 of the 95 patients in the IG reached the MIC (a change in the score beyond which an individual is considered to have a clinical change provided by TKA) for the WOMAC total, whereas 21 patients had reached the MIC in the CG at this point. We believe that our significant results were due to the following factors: 1 – the patients were completely ignorant of the disease and self-management; 2 - patients had a team of professionals (physicians, a nutritionist, physical therapists, physical educators, occupational therapists, psychologists and social workers) repeating the same messages to aid with initial compliance [70,71]; and 3 - the program emphasized optimal exercise practices, beginning with physical therapy, but aiming for more intense physical fitness practices [34,69,72].

Weight reduction, especially reductions in abdominal fat, as well as all of the consequences that are associated with reduced inflammation, is always the aim of any self-management program for OA [49,50,73]. The IG exhibited reduced weight, whereas the CG did not (Table 5), with this group also not reaching the 5 ​kg or 5% of body weight necessary to reduce the onset of radiographic knee OA and to improve disability [74,75]. The IG exhibited reduced BMI by nearly one point at 24 months. Thirteen of the 95 patients lost 5 ​kg or more at 24 months in the IG, whereas seven patients lost 5 ​kg in the CG. This is an important variable to be addressed, not only because of the progression of KOA [74,75] but also because of general health, thus reducing the risk of conversion from impaired glucose tolerance to diabetes and maintaining lower blood pressure [76]. Changes in WHR (Table 5) exhibited minor changes, with tendencies of better results being observed in the IG group. Long-term programs such as IDEA [63] have shown better results.

The objective measurement of lower limb strength is an important assessment [[77], [78], [79]]. Both groups exhibited improved lower limb muscle strength, according to the FTSST and TUG tests (p ​< ​0.001 for both), and both groups reached the minimal detectable change (MDC) for the TUG test [77]. The FTSST results were better in the IG (p ​= ​0.032, ES 0.156, 95% CI: 0.25 5.53). The objective improvement in muscle strength was observed at 6 months and remained improved in the following evaluations (Table 5), as seen in long-term programs [39,59].

Educational and self-management programs based on models for appropriate care of the disease [80,81] are needed, especially in low- and middle-income countries [82]. The program presented here was based on guidelines [25,[49], [50], [51]] and models [80,81] of appropriate care; however, it should be improved in order for it to achieve the MIC, not only in strength but also in weight loss, pain, function and quality of life. For that we believe that more interventions with the nutrition, psychology, physical therapy and physical fitness groups are necessary to improve understanding and compliance.

5. Conclusion

An educational program focusing on patients with KOA and short-term schooling exhibited a moderate effect on function. In relation to standard care, this two-day educational program improved pain, function and strength faster and with clinically important differences. However, the program must be improved to achieve MICs for weight, pain, function and avoid unnecessary hospitalizations.

Declaration of competing interest

One or more of the authors (MUR, NLRB, FESF, CACS, CHAC, JMRS, MMM, OFNS, MIH, RF, TP, GCC, AFP, GPO and OPC) has received funding from TRB PHARMA – BRASIL; MUR has or may receive payments or benefits from APSEN, MYRALLIS, STERIFARMA, PFIZER, MANTECORP and EMS, but these payments are not related to this research; RF has or may receive payments or benefits from APSEN that are not related to this research; GCC has or may receive payments or benefits from SANOFI-AVENTS, ABBOTT and APSEN, but these payments are not related to this research; GPO has or may receive payments or benefits from APSEN, MYLAN and EUROFARMA, but these payments are not related to this research.

Acknowledgments

This study could not have been performed without the voluntary help of Paulo Dallari, Miriam Damaris Di Maio, TRB Pharma Brasil, the secretaries (especially Suellen Lima, Livia Abreu and Natalia Borges), the occupational therapist team, the social workers, the psychologists, the physical educators and the security staff and patients of the Hospital das Clinicas, Department of Orthopaedics, Faculdade de Medicina Universidade de São Paulo.

Footnotes

Appendix A

Supplementary data to this article can be found online at https://doi.org/10.1016/j.ocarto.2020.100137.

Contributor Information

MU Rezende, Email: marcia.uchoa@hc.fm.usp.br.

NLR Brito, Email: nadia.brito@hc.fm.usp.br.

FES Farias, Email: fabisa@hotmail.com.

CAC Silva, Email: cleidneia.acsilva@hc.fm.usp.br.

CHA Cernigoy, Email: claudia.cernigoy@hc.fm.usp.br.

JM Rodrigues da Silva, Email: capoeiragafa@hotmail.com.

MM Moreira, Email: merilu.moreira@hc.fm.usp.br.

OFN Santana, Email: olga.santana@hc.fm.usp.br.

MI Hissadomi, Email: ma_issao@hotmail.com.

R Frucchi, Email: renatofrucchi@hotmail.com.br.

T Pasqualin, Email: thiagopasqualin@gmail.com.

GC Campos, Email: gustavoconstantinocampos@gmail.com.

AF Pailo, Email: alexandrepailo@yahoo.com.br.

GP Ocampos, Email: drguilhermeocampos@gmail.com.

OP Camargo, Email: olavo.camargo@hc.fm.usp.br.

Authors’ contributions

AFP: conception and design; CACS: conception and design; CHAC: conception and design, final approval of the article; FESF: conception and design; GCC: analysis and interpretation of the data; drafting of the article; critical revision of the article for important intellectual content; final approval of the article; GPO: conception and design; critical revision of the article for important intellectual content; JMRS: conception and design; drafting of the article; MIH: conception and design; MMM: conception and design; MUR: conception and design; analysis and interpretation of the data; drafting of the article; critical revision of the article for important intellectual content; final approval of the article; provision of the study materials or patients; obtaining of funding; administrative, technical or logistic support; collection and assembly of data; NLRB: conception and design; final approval of the article; OFNS: conception and design; OPC: final approval of the article; RF: conception and design; TP: conception and design.

Role of the funding source

This study was funded by the Department of Orthopedics (Hospital das Clínicas), Faculdade de Medicina da Universidade de São Paulo, with the participation of TRB Pharma Brasil.

The Department of Orthopedics (Hospital das Clínicas), Faculdade de Medicina da Universidade de São Paulo, supplied the laboratory and imaging exams, the physical structure, the human participants (both professional individuals and patients) and the medications.

TRB Pharma Brasil funded the logistical and audio-visual material of the program as well as the statistics and meeting presentations of the program.

Ethical review committee statement

Ethics Committee for Analysis Certificate - CAAE 37436114.6.0000.0068.

Clinical Trials registration number: NTC 02335034.

Appendix A. Supplementary data

The following are the Supplementary data to this article:

Multimedia component 1
mmc1.docx (57.2KB, docx)
Multimedia component 2
mmc2.pdf (77.9KB, pdf)

References

  • 1.Sanchez-Adams J., Leddy H.A., L McNulty A., J O’Conor C., Guilak F. The mechanobiology of articular cartilage: bearing the burden of osteoarthritis. Curr. Rheumatol. Rep. 2014;16:451. doi: 10.1007/s11926-014-0451-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Heinegård D., Saxne T. The role of the cartilage matrix in osteoarthritis. Nat. Rev. Rheumatol. 2011;7:50–56. doi: 10.1038/nrrheum.2010.198. [DOI] [PubMed] [Google Scholar]
  • 3.Wang B., Liu Q., L Wise B., Ke Y., Xing D., Xu Y., et al. Valgus malalignment and prevalence of lateral compartmental radiographic knee osteoarthritis (OA): the Wuchuan OA study. Int J Rheum Dis. 2018;21:1385–1390. doi: 10.1111/1756-185X.13079. [DOI] [PubMed] [Google Scholar]
  • 4.Sharma L., Chang A.H., D Jackson R., Nevitt M., Moisio K.C., Hochberg M., et al. Varus thrust and incident and progressive knee osteoarthritis. Arthritis Rheum. 2017;69:2136–2143. doi: 10.1002/art.40224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Wink A.E., Gross K.D., Brown C.A., Guermazi A., Roemer F., Niu J., et al. Varus thrust during walking and the risk of incident and worsening medial tibiofemoral MRI lesions: the multicenter osteoarthritis study. Osteoarthritis Cartilage. 2017;25:839–845. doi: 10.1016/j.joca.2017.01.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Hecht N., Johnstone B., Angele P., Walker T., Richter W. Mechanosensitive MiRs regulated by anabolic and catabolic loading of human cartilage. Osteoarthritis Cartilage. 2019;27:208–218. doi: 10.1016/j.joca.2019.04.010. [DOI] [PubMed] [Google Scholar]
  • 7.Wang T., He C. Pro-inflammatory cytokines: the link between obesity and osteoarthritis. Cytokine Growth Factor Rev. 2018;44:38–50. doi: 10.1016/j.cytogfr.2018.10.002. [DOI] [PubMed] [Google Scholar]
  • 8.Schott E.M., Farnsworth C.W., Grier A., Lillis J.A., Soniwala S., Dadourian G.H., et al. Targeting the gut microbiome to treat the osteoarthritis of obesity. JCI Insight. 2018;3 doi: 10.1172/jci.insight.95997. e95997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Ibáñez L., Rouleau M., Wakkach A., Blin-Wakkach C. Gut microbiome and bone. Joint Bone Spine. 2019;86:43–47. doi: 10.1016/j.jbspin.2018.02.008. [DOI] [PubMed] [Google Scholar]
  • 10.Jafarzadeh S.R., Felson D.T. Updated estimates suggest a much higher prevalence of arthritis in United States adults than previous ones. Arthritis Rheum. 2018;70:185–192. doi: 10.1002/art.40355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.World Health Organization . WHO; Switzerland: 2008. The Global Burden of Disease: 2004 Update. [Google Scholar]
  • 12.Sandell L.J. Etiology of osteoarthritis: genetics and synovial joint development. Nat. Rev. Rheumatol. 2012;8:77–89. doi: 10.1038/nrrheum.2011.199. [DOI] [PubMed] [Google Scholar]
  • 13.Blagojevic M., Jinks C., Jeffery A., Jordan K.P. Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthritis Cartilage. 2010;18:24–33. doi: 10.1016/j.joca.2009.08.010. [DOI] [PubMed] [Google Scholar]
  • 14.Ng M., Fleming T., Robinson M., Thomson B., Graetz N., Margono C., et al. Lancet. 2014;384:766–781. doi: 10.1016/S0140-6736(14)60460-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Robine J.M., Cubaynes S. Worldwide demography of centenarians. Mech. Ageing Dev. 2017;165:59–67. doi: 10.1016/j.mad.2017.03.004. [DOI] [PubMed] [Google Scholar]
  • 16.Jørgensen K.T., Pedersen B.V., Nielsen N.M., Hansen A.V., Jacobsen S., Frisch M. Socio-demographic factors, reproductive history and risk of osteoarthritis in a cohort of 4.6 million Danish women and men. Osteoarthritis Cartilage. 2011;19:1176–1182. doi: 10.1016/j.joca.2011.07.009. [DOI] [PubMed] [Google Scholar]
  • 17.IBGE Projection of the Brazil’s population and the Federation Units [internet]. Available at: https://www.ibge.gov.br/apps/populacao/projecao/index.html?utm_source=portal&amp;utm_medium=popclock&amp;utm_campaign=novo_popclock Accessed 10 July 2019.
  • 18.IBGE Agência de Notícias . 2018. IBGE Discloses Household Income Per Capita.https://agenciadenoticias.ibge.gov.br/agencia-sala-de-imprensa/2013-agencia-de-noticias/releases/23852-ibge-divulga-o-rendimento-domiciliar-per-capita-2018 Accessed 10 July 2019. [Google Scholar]
  • 19.IBGE Agência de Notícias National Household Sample Survey 2016: 51% of the population aged 25 or over in Brazil had at most completed elementary school [internet]. Available at. https://agenciadenoticias.ibge.gov.br/agencia-sala-de-imprensa/2013-agencia-de-noticias/releases/18992-pnad-continua-2016-51-da-populacao-com-25-anos-ou-mais-do-brasil-possuiam-no-maximo-o-ensino-fundamental-completo Accessed 10 July 2019.
  • 20.IBGE, National health survey: 2013 . IBGE; Rio de Janeiro: 2015. Life Cycles: Brazil and Large Regions. [Google Scholar]
  • 21.IBGE . IBGE; Rio de Janeiro: 2015. Sport and Physical Activity Practices: 2015. [Google Scholar]
  • 22.Zhang W., Nuki G., Moskowitz R.W., Abramson S., Altman R.D., Arden Nk N.K., et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage. 2010;18:476–499. doi: 10.1016/j.joca.2010.01.013. [DOI] [PubMed] [Google Scholar]
  • 23.McAlindon T.E., R Bannuru R., C Sullivan M., Arden N.K., Berenbaum F., Bierma-Zeinstra S.M., et al. Corrigendum to ‘2014 OARSI guidelines for the non-surgical management of knee osteoarthritis’. Osteoarthritis Cartilage. 2014;22:363–388. doi: 10.1016/j.joca.2014.01.003. Osteoarthritis and Cartilage. 23 (2015) 1026-34. [DOI] [PubMed] [Google Scholar]
  • 24.Bruyère O., Cooper C., Pelletier J.P., Branco J., Luisa Brandi M., et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) Semin. Arthritis Rheum. 2014;44:253–263. doi: 10.1016/j.semarthrit.2014.05.014. [DOI] [PubMed] [Google Scholar]
  • 25.Rillo O., Riera H., Acosta C., Liendo V., Bolaños J., Monterola L., et al. PANLAR Consensus recommendations for the management in osteoarthritis of hand, hip, and knee. J. Clin. Rheumatol. 2016;22:345–354. doi: 10.1097/RHU.0000000000000449. [DOI] [PubMed] [Google Scholar]
  • 26.Bowden J.L., Hunter D.J., Deveza L.A., Duong V., Dziedzic K.S., Allen K.D., K Chan P., Eyles J.P. Core and adjunctive interventions for osteoarthritis: efficacy and models for implementation. Nat. Rev. Rheumatol. 2020;16:434–447. doi: 10.1038/s41584-020-0447-8. [DOI] [PubMed] [Google Scholar]
  • 27.Kroon F.P., van der Burg L.R., Buchbinder R., Osborne R.H., Johnston R.V., Pitt V. Self-management education programmes for osteoarthritis. Cochrane Database Syst. Rev. 2014;1:CD008963. doi: 10.1002/14651858.CD008963.pub2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.United Nations, Department of Economic, Affairs Social, Division Population. United Nations; New York: 2017. World Population Ageing 2017 Highlights.https://www.un.org/en/development/desa/population/publications/pdf/ageing/WPA2017_Highlights.pdf Accessed 29 April 2020. [Google Scholar]
  • 29.Blüher M. Obesity: global epidemiology and pathogenesis. Nat. Rev. Endocrinol. 2019;15:288–298. doi: 10.1038/s41574-019-0176-8. [DOI] [PubMed] [Google Scholar]
  • 30.Rezende M.U., Frucchi R., Pailo A.F., Campos G.C., Pasqualin T., Hissadomi M.I. PARQVE: project arthritis recovering quality of life through education: two-year results. Acta Ortopédica Bras. 2017;25:18–24. doi: 10.1590/1413-785220172501165604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.de Rezende M.U., Hissadomi M.I., de Campos G.C., Frucchi R., Pailo A.F., Pasqualin T., et al. One-year results of an educational program on osteoarthritis: a prospective randomized controlled trial in Brazil. Geriatr Orthop Surg Rehabil. 2016;7:86–94. doi: 10.1177/2151458516645634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Moher D., Hopewell S., Schulz K.F., Montori V., Gøtzsche P.C., Devereaux P.J., et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int. J. Surg. 2012;10:28–55. doi: 10.1016/j.ijsu.2011.10.001. [DOI] [PubMed] [Google Scholar]
  • 33.de Rezende M.U., de Campos G.C., Pailo A.F., Frucchi F., Pasqualin T., Camargo O.P. PARQVE-Project arthritis recovering quality of life by means of education short-term outcome in a randomized clinical trial. J. Arthritis. 2013;2:113. doi: 10.4172/2167-7921.1000113. [DOI] [Google Scholar]
  • 34.Rodrigues da Silva J.M., de Rezende M.U., Spada T.C., da Silva Francisco L., Sabine de Farias F.E., et al. Educational program promoting regular physical exercise improves functional capacity and daily living physical activity in subjects with knee osteoarthritis. BMC Muscoskel. Disord. 2017;18:546. doi: 10.1186/s12891-017-1912-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Borg G. Perceived exertion as an indicator of somatic stress. Scand. J. Rehabil. Med. 1970;2:92–98. [PubMed] [Google Scholar]
  • 36.U de Rezende M. first ed. São Paulo; Revinter: 2015. Tratamento Multiprofissional da Artrose. [Google Scholar]
  • 37.Kreuter M.W., Lukwago S.N., Bucholtz R.D., Clark E.M., Sanders-Thompson V. Achieving cultural appropriateness in health promotion programs: targeted and tailored approaches. Health Educ. Behav. 2003;30:133–146. doi: 10.1177/1090198102251021. [DOI] [PubMed] [Google Scholar]
  • 38.Rothman A.J., Bartels R.D., Wlaschin J., Salovey P. The strategic use of gain- and loss-framed messages to promote healthy behavior: how theory can inform practice. J. Commun. 2006;56 doi: 10.1111/j.1460-2466.2006.00290.x. S202–S220. [DOI] [Google Scholar]
  • 39.Hurley M.V., Walsh N.E., Mitchell H., Nicholas J., Patel A. Long-term outcomes and costs of an integrated rehabilitation program for chronic knee pain: a pragmatic, cluster randomized, controlled trial. Arthritis Care Res. 2012;64:238–247. doi: 10.1002/acr.20642. [DOI] [PubMed] [Google Scholar]
  • 40.Fernandes M.I. 2003. Translation and Validation of the WOMAC (Western Ontario McMaster Universities) Specific Quality of Life Questionnaire for Osteoarthritis into Portuguese (Dissertation)http://repositorio.unifesp.br/handle/11600/19401 Accessed 31 March 2020. [Google Scholar]
  • 41.Jackson A.S., Pollock M.L., Ward A. Generalized equations for predicting body density of women. Med. Sci. Sports Exerc. 1980;12:175–181. [PubMed] [Google Scholar]
  • 42.Kissebah A.H., Krakower G.R. Regional adiposity and morbidity. Physiol. Rev. 1994;74:761–811. doi: 10.1152/physrev.1994.74.4.761. [DOI] [PubMed] [Google Scholar]
  • 43.Dutra M.C., Cabral A.L.L., Carvalho G.A. Translation into Portuguese and validation of the timed up and go test. Interfaces. 2016;3:81–88. doi: 10.1590/1413-785220172501165604. [DOI] [Google Scholar]
  • 44.Lira V.A., Araújo C.G.S. Sitting-rising test: reliability studies. Rev. Bras. Ciência Mov. 2000;8:179–182. [Google Scholar]
  • 45.Angst F., Aeschlimann A., Stucki G. Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities. Arthritis Rheum. 2001;45 doi: 10.1002/1529-0131(200108)45:4&#x0003c;384::AID-ART352&#x0003e;3.0.CO;2-0. 384-91. [DOI] [PubMed] [Google Scholar]
  • 46.Hurley M.V., Walsh N., Bhavnani V., Britten N., Stevenson F. Health beliefs before and after participation on an exercised-based rehabilitation programme for chronic knee pain: doing is believing. BMC Muscoskel. Disord. 2010;11:31. doi: 10.1186/1471-2474-11-31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Clement N.D., Bardgett M., Weir D., Holland J., Gerrand C., Deehan D.J. Erratum to: what is the minimum clinically important difference for the womac index after TKA? Clin. Orthop. Relat. Res. 2020;478:922. doi: 10.1097/CORR.0000000000001156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Thorstensson C.A., Garellick G., Rystedt H., Dahlberg L.E. Better management of patients with osteoarthritis: development and nationwide implementation of an evidence-based supported osteoarthritis self-management Programme. Muscoskel. Care. 2015;13:67–75. doi: 10.1002/msc.1085. [DOI] [PubMed] [Google Scholar]
  • 49.Bannuru R.R., Osani M.C., Vaysbrot E.E., Arden N.K., Bennell K., Bierma-Zeinstra S.M.A., et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27:1578–1589. doi: 10.1016/j.joca.2019.06.011. [DOI] [PubMed] [Google Scholar]
  • 50.Biver E., Berenbaum F., Valdes A.M., Araujo de Carvalho I., Bindels L.B., Brandi M.L., et al. Gut microbiota and osteoarthritis management: an expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO) Ageing Res. Rev. 2019;55:100946. doi: 10.1016/j.arr.2019.100946. [DOI] [PubMed] [Google Scholar]
  • 51.Richmond J., Hunter D., Irrgang J., Jones M.H., Snyder-Mackler L., Van Durme D., et al. American Academy of Orthopaedic Surgeons clinical practice guideline on the treatment of osteoarthritis (OA) of the knee. J Bone Joint Surg Am. 2010;92:990–993. doi: 10.2106/JBJS.I.00982. [DOI] [PubMed] [Google Scholar]
  • 52.Robinson W.H., Lepus C.M., Wang Q., Raghu H., Mao R., Lindstrom T.M., Sokolove J. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat. Rev. Rheumatol. 2016;12:580–592. doi: 10.1038/nrrheum.2016.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Scanzello C.R. Role of low-grade inflammation in osteoarthritis. Curr. Opin. Rheumatol. 2017;29:79–85. doi: 10.1097/BOR.0000000000000353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Minguzzi M., Cetrullo S., D’Adamo S., Silvestri Y., Flamigni F., Borzì R.M. Emerging Players at the intersection of chondrocyte loss of maturational arrest, oxidative stress, senescence and low-grade inflammation in osteoarthritis. Oxid Med Cell Longev. 2018:3075293. doi: 10.1155/2018/3075293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Courties A., Berenbaum F., Sella J. The phenotypic approach to osteoarthritis: a look at metabolic syndrome-associated osteoarthritis. Joint Bone Spine. 2019;86:725–730. doi: 10.1016/j.jbspin.2018.12.005. [DOI] [PubMed] [Google Scholar]
  • 56.Romera Baures M., Morales Ivorra I. Mediterranean diet and osteoarthritis. Reumatol. Clínica. 2019;15:125–126. doi: 10.1016/j.reuma.2018.12.001. [DOI] [PubMed] [Google Scholar]
  • 57.Ackerman I.N., Buchbinder R., Osborne R.H. Challenges in evaluating an arthritis self-management program for people with hip and knee osteoarthritis in real-world clinical settings. J. Rheumatol. 2012;39:1047–1055. doi: 10.3899/jrheum.111358. [DOI] [PubMed] [Google Scholar]
  • 58.Kroon F.P.B., van der Burg L.R.A., Buchbinder R., Osborne R.H., Johnston R.V., Pitt V. Self-management education programmes for osteoarthritis. Cochrane Database Syst. Rev. 2014;1:CD008963. doi: 10.1002/14651858.CD008963.pub2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Jönsson T., Eek F., Dell’Isola A., Dahlberg L.E., Ekvall Hansson E. The better management of patients with osteoarthritis program: outcomes after evidence-based education and exercise delivered nationwide in Sweden. PloS One. 2019;14 doi: 10.1371/journal.pone.0222657. e0222657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Allen K.D., Oddone E.Z., Coffman C.J., Datta S.K., Juntilla K.A., Lindquist J.H., et al. Telephone-based self-management of osteoarthritis: a randomized trial. Ann. Intern. Med. 2010;153:570–579. doi: 10.7326/0003-4819-153-9-201011020-00006. [DOI] [PubMed] [Google Scholar]
  • 61.Hansson E.E., Jönsson-Lundgren M., M Ronnheden A., Sörensson E., Bjärnung A., Dahlberg L.E. Effect of an education programme for patients with osteoarthritis in primary care--a randomized controlled trial. BMC Muscoskel. Disord. 2010;11:244. doi: 10.1186/1471-2474-11-244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Ravaud P., Flipo R.M., Boutron I., Roy C., Mahmoudi A., Giraudeau B., et al. ARTIST (osteoarthritis intervention standardized) study of standardised consultation versus usual care for patients with osteoarthritis of the knee in primary care in France: pragmatic randomised controlled trial. BMJ. 2009;338:b421. doi: 10.1136/bmj.b421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Messier S.P., Mihalko S.L., Legault C., Miller G.D., J Nicklas B., DeVita P., et al. Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial. J. Am. Med. Assoc. 2013;310:1263–1273. doi: 10.1001/jama.2013.277669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Plapler P.G., Rodrigues T., de Rezende M.U. Education and physical activity in osteoporosis. J Osteopor Phys Act. 2014:2. doi: 10.4172/2329-9509.1000118. 02. [DOI] [Google Scholar]
  • 65.Brito N.L.R., de Rezende M.U., Pasqualin T., Campos G.C., Frucchi R., Hissadomi M.I., et al. Analysis of anthropometric measurements and dietary intake in patients undergoing a multi-professional osteoarthritis education program (PARQVE-Project Arthritis Recovering Quality of Life by Means of Education) Open J. Orthoped. 2016;6:32–45. doi: 10.4236/ojo.2016.62006. [DOI] [Google Scholar]
  • 66.Rezende M.U., Hissadomi M.I., Frucchi R., Campo G.C., Pailo A.F., Pasqualin T., et al. PARQVE – project arthritis recovering quality of life by means of education. one-year follow-up. effects on pain, function, BMI and quality of life of the educational program, coping skills and level of education. Osteoarthritis Cartilage. 2014;22:S196. doi: 10.1016/j.joca.2014.02.374. [DOI] [Google Scholar]
  • 67.Campos G.C., Kohara M.T., Rezende M.U., Santana O.F.M., Moreira M.M., Camargo O.P., et al. Schooling of the patients and clinical application of questionnaires in osteoarthitis. Acta Ortopédica Bras. 2014;22:256–259. doi: 10.1590/1413-78522014220500980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.McAlindon T.E., Bannuru R.R., Sullivan M.C., et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22:363–388. doi: 10.1016/j.joca.2014.01.003. [DOI] [PubMed] [Google Scholar]
  • 69.Kirihara R.A., Catelan F.B., Farias F.E., Silva C.A., Cernigoy C.H.A., de Rezende M.U., et al. Intensity, duration and type of physical activity required to improve function in knee osteoarthritis. Acta Ortopédica Bras. 2017;25:25–29. doi: 10.1590/1413-785220172501166212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Campbell R., Evans M., Tucker M., Quilty B., Dieppe P., Donovan J.L. Why don’t patients do their exercises? Understanding non-compliance with physiotherapy in patients with osteoarthritis of the knee. J. Epidemiol. Community Health. 2001;55:132–138. doi: 10.1136/jech.55.2.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Bennell K.L., Dobson F., Hinman R.S. Exercise in osteoarthritis: moving from prescription to adherence. Best Pract. Res. Clin. Rheumatol. 2014;28:93–117. doi: 10.1016/j.berh.2014.01.009. [DOI] [PubMed] [Google Scholar]
  • 72.Rodrigues da Silva J.M., de Rezende M.U., Spada T.C., da Silva Francisco L., dos Santos H.P., de Andrade Souza R., et al. Muscular and functional capacity in subjects under treatment for knee osteoarthritis: role of physical activity status. J. Phys. Activ. Health. 2019;16:362–367. doi: 10.1123/jpah.2018-0318. [DOI] [PubMed] [Google Scholar]
  • 73.Duclos M. Osteoarthritis, obesity and type 2 diabetes: the weight of waist circumference. Ann Phys Rehabil Med. 2016;59:157–160. doi: 10.1016/j.rehab.2016.04.002. [DOI] [PubMed] [Google Scholar]
  • 74.Runhaar J., de Vos B.C., van Middelkoop M., Vroegindeweij D., Oei E.H., Bierma-Zeinstra S.M. Prevention of incident knee osteoarthritis by moderate weight loss in overweight and obese females. Arthritis Care Res. 2016;68:1428–1433. doi: 10.1002/acr.22854. [DOI] [PubMed] [Google Scholar]
  • 75.Christensen R., Bartels E.M., Astrup A., Bliddal H. Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis. Ann. Rheum. Dis. 2007;66:433–439. doi: 10.1136/ard.2006.065904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Obesity Management Interventions Delivered in Primary Care for Patients with Hypertension or Cardiovascular Disease: a Review of Clinical Effectiveness [Internet] Canadian Agency for Drugs and Technologies in Health; Ottawa (ON): 2014. [PubMed] [Google Scholar]
  • 77.Alghadir A., Anwer S., Brismée J.M. The reliability and minimal detectable change of Timed up and Go test in individuals with grade 1-3 knee osteoarthritis. BMC Muscoskel. Disord. 2015;16:174. doi: 10.1186/s12891-015-0637-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Alcazar J., Losa-Reyna J., Rodriguez-Lopez C., Alfaro-Acha A., Rodriguez-Mañas L., Ara I., et al. The sit-to-stand muscle power test: an easy, inexpensive and portable procedure to assess muscle power in older people. Exp. Gerontol. 2018;112:38–43. doi: 10.1016/j.exger.2018.08.006. [DOI] [PubMed] [Google Scholar]
  • 79.de Rezende M.U., de Farias F.E.S., da Silva C.A.C., Cernigoy C.H.A., de Camargo O.P. Objective functional results in patients with knee osteoarthritis submitted to a 2-day educational programme: a prospective randomised clinical trial. BMJ Open Sport Exerc Med. 2017;2 doi: 10.1136/bmjsem-2016-000200. e000200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Allen K.D., Choong P.F., Davis A.M., Dowsey M.M., Dziedzic K.S., Emery C., et al. Osteoarthritis: models for appropriate care across the disease continuum. Best Pract. Res. Clin. Rheumatol. 2016;30:503–535. doi: 10.1016/j.berh.2016.09.003. [DOI] [PubMed] [Google Scholar]
  • 81.Bowden J.L., Hunter D.J., Deveza L.A., Duong V., Dziedzic K.S., Allen K.D., et al. Core and adjunctive interventions for osteoarthritis: efficacy and models for implementation. Nat. Rev. Rheumatol. 2020;16:434–447. doi: 10.1038/s41584-020-0447-8. [DOI] [PubMed] [Google Scholar]
  • 82.Eyles J.P., Hunter D.J., Bennell K.L., Dziedzic K.S., Hinman R.S., van der Esch M., et al. Priorities for the effective implementation of osteoarthritis management programs: an OARSI international consensus exercise. Osteoarthritis Cartilage. 2019;27:1270–1279. doi: 10.1016/j.joca.2019.05.015. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Multimedia component 1
mmc1.docx (57.2KB, docx)
Multimedia component 2
mmc2.pdf (77.9KB, pdf)

Articles from Osteoarthritis and Cartilage Open are provided here courtesy of Elsevier

RESOURCES